Latest News

Sienna Appoints Dr John Chiplin Non-Executive Director 22-Jan-2016

Sienna Cancer Diagnostics Ltd is pleased to announce the appointment of Dr John Chiplin to the B.. READ MORE

Sienna Receives R&D Tax Refund 19-Jan-2016

Sienna Cancer Diagnostics Ltd today announced it has received a $682,921 Research & Developm.. READ MORE

Johns Hopkins abstract accepted for presentation at USCAP 20-Nov-2015

In March 2016, researchers from the Johns Hopkins Hospital will present results of a study exami.. READ MORE

Investor Information

Sienna is a public unlisted company headquartered in Melbourne, Australia. It has recently transitioned from a purely Research and Development company to a true commercial entity with product revenues. The company has approximately 135 shareholders and is governed by an experienced board and management team, Sienna has benefited from over $4M in government grants, significantly bolstering investor contributions and facilitating the progress and growth to date. READ MORE

Research

Sienna’s core activities have historically focused on the clinical translation of biomarkers using novel diagnostic technologies for applications in pathology laboratories. The development of inexpensive, high performing in-vitro diagnostic tests is expected to lead to radical changes in the approach to care and assessment of cancer patients – a change welcomed by clinicians and governments. READ MORE

About Sienna

Sienna is a biotechnology company focussed on the development and commercialisation of novel IVD (in vitro diagnostic) tests. Sienna manufactures individual component products for research institutions and pathology laboratories to use in research or in their own laboratory developed tests. Sienna registered their first product with the FDA in 2014, the Anti-hTERT antibody (SCD-A7). READ MORE

Sienna’s experienced and diverse team was responsible for the launch of the company's first product in the USA, the Anti-hTERT antibody (SCD-A7).

– CEO, Dr Cliff Holloway

Sign up to our newsletter

Contact Sienna

Sienna Cancer Diagnostics

1 Dalmore Drive Scoresby VIC 3179 Australia

Telephone +61 3 8288 2141 Facsimile +61 3 8288 2059